Lunsekimig

Approval Year

Name

Type

Language

Lunsekimig

Official Name

English

Immunoglobulin single chain of 5 VH (sc-5-VH), anti-[Homo sapiens IL13 (interleukin 13, IL-13)], anti-[Homo sapiens TSLP (thymic stromal lymphopoietin)] and anti-[Homo sapiens ALB (albumin, human serum albumin, HAS)], monoclonal antibody sc-5-VH, humaniz

Common Name

English

Single chain of 5 VH (sc-5-VH) humanized and chimeric (1-671)[VH anti-IL13 chimeric Vicpac/Homsap (Vicugna pacos IGHV3-3*01 (87.6%) -(IGHD) -IGHJ2*01 (100%)/Homo sapiens IGHV3-23*04 (81.4%) -(IGHD) -IGHJ4*01 (85.7%), L50>R (45), CDR-IMGT [8.8.16] (26-33.

Common Name

English

lunsekimig [INN]

Common Name

English

Code System Code Type Description

CAS

2770858-49-4

Created by admin on Sat Dec 16 19:58:13 GMT 2023 , Edited by admin on Sat Dec 16 19:58:13 GMT 2023

PRIMARY

INN

12833

Created by admin on Sat Dec 16 19:58:13 GMT 2023 , Edited by admin on Sat Dec 16 19:58:13 GMT 2023

PRIMARY

FDA UNII

VYR5R5XN5A

Created by admin on Sat Dec 16 19:58:13 GMT 2023 , Edited by admin on Sat Dec 16 19:58:13 GMT 2023

PRIMARY

ACTIVE MOIETY


					VYR5R5XN5A

Lunsekimig